— Know what they know.
Not Investment Advice

ICAD NASDAQ

iCAD, Inc.
1W: -0.3% 1M: +1.0% 3M: +100.5% 1Y: +209.6% 3Y: -8.5% 5Y: -58.8%
$3.87
Last traded 2025-07-17 — delisted
NASDAQ · Healthcare · Medical - Devices · $106.3M mcap · 26M float · 3.06% daily turnover · Short 32% of daily vol

Balance Sheet Trends

Total Assets
$38M -9.4% ▼
5Y CAGR: -2.1%
Total Liabilities
$9M +10.7% ▲
5Y CAGR: -24.7%
Shareholders Equity
$29M -14.2% ▼
5Y CAGR: +41.4%
Cash & Investments
$17M -20.6% ▼
5Y CAGR: +2.4%
Total Debt
$362K -21.5% ▼
5Y CAGR: -56.2%
Net Debt
-$17M +20.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$27M$34M$21M$22M$17M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$27M$34M$21M$22M$17M
Net Receivables$11M$11M$10M$6M$7M
Inventory$3M$4M$5M$917K$756K
Other Current Assets-$481K-$2M$3M$699K$1M
Total Current Assets$42M$50M$38M$30M$26M
Property, Plant & Equip.$3M$2M$4M$2M$2M
Goodwill & Intangibles$9M$9M$9M$9M$8M
Long-Term Investments$0$0$15K$0$0
Other Non-Current Assets$2M$899K$54K$849K$757K
Total Non-Current Assets$13M$12M$13M$12M$11M
Total Assets$56M$62M$52M$41M$38M
— Liabilities —
Accounts Payable$3M$3M$1M$712K$1M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$6M$6M$6M$3M$4M
Other Current Liabilities$0$0$4M$3M$1M
Total Current Liabilities$17M$15M$13M$7M$8M
Long-Term Debt$7M$0$0$0$0
Other Non-Current Liab.$0$0$2M$0$17K
Total Non-Current Liabilities$8M$712K$3M$1M$1M
Total Liabilities$25M$16M$17M$8M$9M
— Equity —
Common Stock$236K$253K$254K$265K$265K
Retained Earnings-$242M-$253M-$267M-$272M-$277M
Accumulated OCI-$0$0$0-$0$0
Total Stockholders Equity$31M$47M$35M$33M$29M
Total Liabilities & Equity$56M$62M$52M$41M$38M
— Key Metrics —
Total Debt$9M$1M$672K$461K$362K
Net Debt-$18M-$33M-$21M-$21M-$17M
Total Investments$0$0$15K$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms